Vugmeyster Yulia - Department of Pharmacokinetics, Dynamics, and Metabolism, Pfizer Inc

Valerie Nicolas-Metral,Elisabeth Rouits, Camille Riff, Dany Spaggiari, Norbert Wiedemann, Pierre Colin, Eleanor Harrison-Moench, Rafael Crabbe,Heidi Nauwelaerts, Andreas Schroeder, Carolina Haefliger,Yulia Vugmeyster

CANCER RESEARCHno. 7 (2024)

Cited0Views0Bibtex

Abstract CT140: A Phase 1 Study of the IAP Inhibitor Xevinapant (debio 1143) to Evaluate Food Effect and Drug-Drug Interactions with a Proton Pump Inhibitor in Healthy Volunteers

Valérie Nicolas-Métral,Elisabeth Rouits,Camille Riff,Dany Spaggiari,Norbert Wiedemann, Pierre Colin,Eleanor Harrison-Moench,Rafael Crabbé,Heidi Nauwelaerts,Andreas Schroeder, Carolina Haefliger,Yulia Vugmeyster

Cancer Researchno. 7_Supplement (2024)

Cited0Views0Bibtex

Data from Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical Cancer

Ana Oaknin,Sharad A. Ghamande,Yuka Kasamatsu,Marta Gil-Martin,Juan Francisco Grau-Bejar,Carmen Garcia-Duran,Masashi Sato, Abdul Siddiqui,Surendra Pal Chaudhary,Yulia Vugmeyster,Kosei Hasegawa

CLINICAL CANCER RESEARCHno. 5 (2024): 975-983

Cited0Views0WOSBibtex

Efficacy and Safety of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, Plus Chemotherapy in Patients with Stage IV NSCLC

Christian Rolfo, Laurent Greillier,Remi Veillon,Firas Badin,Francois Ghiringhelli,Nicolas Isambert,Astrid Paulus,Surendra Pal Chaudhary,Yulia Vugmeyster,Masashi Sato,Sandrine Hiret

JTO Clinical and Research Reports (2024)

Cited0Views0Bibtex

Efficacy, Safety, and Biomarker Analyses of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Advanced Non-Small Cell Lung Cancer

Arun Rajan,Houssein Abdul Sater,Osama Rahma, Richy Agajanian,Wiem Lassoued,Jennifer L. Marte,Yo-Ting Tsai,Renee N. Donahue,Elizabeth Lamping,Shania Bailey, Andrew Weisman, Beatriz Walter-Rodriguez,Rena Ito,Yulia Vugmeyster,Masashi Sato,Andreas Machl,Jeffrey Schlom,James L. Gulley

JOURNAL FOR IMMUNOTHERAPY OF CANCERno. 3 (2024)

Cited0Views0WOSBibtex

Supplementary Table S1 from Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical Cancer

Ana Oaknin,Sharad A. Ghamande,Yuka Kasamatsu,Marta Gil-Martin,Juan Francisco Grau-Bejar,Carmen Garcia-Duran,Masashi Sato, Abdul Siddiqui,Surendra Pal Chaudhary,Yulia Vugmeyster,Kosei Hasegawa

openalex（2024）

Cited0Views0Bibtex

Supplementary Table S2 from Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical Cancer

Ana Oaknin,Sharad Ghamande,Yuka Kasamatsu,Marta Gil-Martín,Juan Francisco Grau-Béjar,Carmen García-Durán,Masashi Sato, Abdul Siddiqui,Surendra Pal Chaudhary,Yulia Vugmeyster,Kosei Hasegawa

openalex（2024）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn